Morocco Seeks to Boost Tourism in Western Sahara Amid Sovereignty Dispute SpaceX Scrub of Starship Test Flight Delays Debut of NextGeneration Rocket Niva Bupa Aims to Secure Top Two Retail Health Insurance Position Within Three Years Investors Flock to HALO Stocks A New ETF Captures the AIProof Theme Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend Vickers Insider Trading Report Top Buyers and Sellers for May 28 2026 Enveric Biosciences Inc ENVB Q4 2024 Earnings Massive EPS Miss Highlights Ongoing Cash Burn and No Revenue NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance CGBD Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance RKLB Q1 2026 Earnings EPS Beats Estimates as Rocket Lab Narrows Losses NewMarket Corp NEU Q1 2026 Earnings Robust EPS Performance Drives Positive Market Response Bone Biologics Corp BBLG Q1 2026 Earnings Narrower Loss Beats Estimates Shares Dip Data IO Corporation DAIO Navigates Technical Crossroads After Modest Decline Pitney Bowes Faces Resistance as Selling Pressure Intensifies KT Corporation KT Faces Downward Pressure as Shares Decline 137 CVRx Inc CVRX Stabilizes Above 6 Support Resistance Test Ahead Blueport Acquisition Rights BPACR Edges Higher as Speculative Trading Volume Picks Up Nvidia Posts Record Earnings But Shares Dip as Growth Concerns Mount PMTU Q1 2026 Earnings Significant EPS Miss as Mortgage Market Pressures Persist Artivion Inc AORT Faces Selling Pressure as Shares Dip Below Key Moving Averages PSX Q1 2026 Earnings EPS Surges Past Estimates Driven by Operational Strength PLAY Q1 2026 Earnings Major EPS Miss Clouds Outlook Stock Inches Higher CDIO Q1 2025 Earnings Narrowerthanexpected loss surprises market BCRX Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Updates GTES Q1 2026 Earnings EPS Beats Estimates by 47 Shares Edge Higher Armata Pharmaceuticals Q1 2026 Earnings Significant EPS Miss but Stock Rises on Pipeline Progress ICCM Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development